Lithium therapy and its interactions

27Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Lithium is one of the most effective mood stabilisers for people with a mood disorder. However, many of these patients are also taking other medicines that could potentially interact with lithium. To minimise the risk of relapse, it is usually necessary to maintain the lithium serum concentration between 0.6 mmol/L and 0.8 mmol/L. Lithium clearance is easily influenced by drugs that alter renal function such as ACE inhibitors, angiotensin receptor antagonists, diuretics, and non-steroidal anti-inflammatory drugs. It is therefore prudent for prescribers to monitor and adjust the lithium dose to avoid adverse effects or loss of efficacy.

Cite

CITATION STYLE

APA

Malhi, G. S., Bell, E., Outhred, T., & Berk, M. (2020). Lithium therapy and its interactions. Australian Prescriber, 43(3), 91–93. https://doi.org/10.18773/austprescr.2020.024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free